4Hbque SN, Graham J, Kaufmann ME, et al. Chryseobacterium meningosepticum outbreak associated with colonization, of water taps in a neonatal intensive care unit [ J ]. J Hosp Infect, 2001,47 ( 3 ) : 188 - 192.
2BELLAIS S, POIREL L, LEOTARD S, et al. Genetic diversity of carbarpennem-hydrolyzing metallo-lactamase from Chryseobacterium (Flavobacterium)[J]. Antimicrob Agents chemother, 2000, 44(11): 3028-3034.
3BELLAIS S, POIREL L, NASS T, et al. Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium(Flavobacterium) meningosepticum [J].Antimicrob Agents Chemother, 2000, 44(1): 1-9.
4Green BT,Nolan PE.Cellulitis and bacteraemia due to Chryseobacterium indologens.J Infect,2001,42(3):219 ～ 220.
5Nulens E,Bussels B,Bols A,et al.Recurrent bacterenmia by Chyseobacterium indologenes in an oncology patient with a totally implanted intravascular device.Clin Microbiol Infect,2001,7(7):391 ～ 393.
6Hoque SN,Graham J,Kaufmann ME,et al.Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization ofwater taps in a neonatal intensive care unit.J Hosp Infect,2001,47(3):188～ 192.
7Rossolini GM,Franceschini N,Lauretti L,et al.Cloning of a Cnryseooactentun meningosepticum chromosomal gene encoding an extendedspectrum class A beta lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta lactamases.Antimicrob Agents Chemother,1999,43(9):2193 ～ 2199.
8Bellais S,Poirel L,Nass T,et al.Genetic biochemical analysis and distrbution of the Ambler class A beta lactamase CME-2,responsible for extended-spectrum cephalosporin resistance in Chryseobacterium meningosepticum.Antimicrob Agents Chemother,2000,44 (1):1 ～ 9.
9BELLAIS S,POIREL L,LEOTARD S,et al.Genetic diversity of carbapenem-hydrolyzing metallo-lactamase from Chryseobacterium (Flavobacterium)[ J ].Antimicrob Agents Chemother,2000,44(11):3028-3034.
10NULENS E,BOLS A.Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device[J].Clin Microbiol Infect,2001,7 (7):391-393.
2Tuon FF, Campos L, Duboc de Almeida G, et al. Chryseobacterium meningosepticum as a cause of cellulitis and sepsis in an immunocompetent patient[J]. J Med Microbiol,2007,56(Pt 8):1116- 1117.
3Ceyhan M, Yildirim I, Tekeli A, et al. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients[J]. Am J Infect Control,2008,36(6) :453 -457.
4Hung PP, Lin YH, Lin CF, et al. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality[J]. J Microbiol Immunol Infect, 2008,41(2) : 137- 144.
5Chen GX,Zhang R, Zhou HW. Heterogeneity of metalol-betalactamases in clinical isolates of Chryseobacterium meningosepticu*n from Hangzhou, China[J].J Antimicrob Chemother, 2006,57(4) : 750-752.
